SDC1 and Miyoshi myopathy: Finally, although the validation of the prognostic potential of CD138+ miR-25 levels by three independent patient cohorts, strongly supports its impact on MM prognostication, further multi-institutional validation will define the optimal cut-off values and procedures to be utilized in clinical setting.